APO RESEARCH · REPORT
Diabetes Injection Pens
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Product & engineering
Understand the product.
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Selected research
Industry Research
Diabetes Injection Pens Industry Research Report 2026
Market perspective
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Global Diabetes Injection Pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top four manufacturers hold a share nearly 65%.
Europe is the largest market, with a share over 40%, followed by Asia-Pacific, and North America, both have a share about 50 percent.
Read the full market overview
In terms of product, Disposable Insulin Pens is the largest segment, with a share over 70%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital and Clinic, Online Sales, etc.
Report Scope
This report quantifies the global Diabetes Injection Pens market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diabetes Injection Pens Market by Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
Diabetes Injection Pens Segment by Type
Reusable Insulin Pens
Disposable Insulin Pens
Diabetes Injection Pens Segment by Application
Hospital and Clinic
Retail Pharmacy
Online Sales
Diabetes Injection Pens Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetes Injection Pens market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetes Injection Pens and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetes Injection Pens.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diabetes Injection Pens manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diabetes Injection Pens by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diabetes Injection Pens in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Insulin Pens
- Disposable Insulin Pens
Applications
- Hospital and Clinic
- Retail Pharmacy
- Online Sales
Companies covered
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
- Delfu
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diabetes Injection Pens Market Size (2021-2032)
- 2.2.2 Global Diabetes Injection Pens Sales (2021-2032)
- 2.2.3 Global Diabetes Injection Pens Market Average Price (2021-2032)
- 2.3 Diabetes Injection Pens by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Reusable Insulin Pens
- 2.3.3 Disposable Insulin Pens
- 2.4 Diabetes Injection Pens by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Retail Pharmacy
- 2.4.4 Online Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diabetes Injection Pens Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diabetes Injection Pens Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Diabetes Injection Pens Revenue of Manufacturers (2021-2026)
- 3.4 Global Diabetes Injection Pens Average Price by Manufacturers (2021-2026)
- 3.5 Global Diabetes Injection Pens Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diabetes Injection Pens, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diabetes Injection Pens, Product Type & Application
- 3.8 Global Manufacturers of Diabetes Injection Pens, Established Date
- 3.9 Global Diabetes Injection Pens Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Diabetes Injection Pens Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Diabetes Injection Pens Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Diabetes Injection Pens Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 BD
- 4.4.1 BD Company Information
- 4.4.2 BD Business Overview
- 4.4.3 BD Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BD Diabetes Injection Pens Product Portfolio
- 4.4.5 BD Recent Developments
- 4.5 Ypsomed Holding
- 4.5.1 Ypsomed Holding Company Information
- 4.5.2 Ypsomed Holding Business Overview
- 4.5.3 Ypsomed Holding Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ypsomed Holding Diabetes Injection Pens Product Portfolio
- 4.5.5 Ypsomed Holding Recent Developments
- 4.6 Dongbao
- 4.6.1 Dongbao Company Information
- 4.6.2 Dongbao Business Overview
- 4.6.3 Dongbao Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dongbao Diabetes Injection Pens Product Portfolio
- 4.6.5 Dongbao Recent Developments
- 4.7 Owen Mumford
- 4.7.1 Owen Mumford Company Information
- 4.7.2 Owen Mumford Business Overview
- 4.7.3 Owen Mumford Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Owen Mumford Diabetes Injection Pens Product Portfolio
- 4.7.5 Owen Mumford Recent Developments
- 4.8 Ganlee
- 4.8.1 Ganlee Company Information
- 4.8.2 Ganlee Business Overview
- 4.8.3 Ganlee Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ganlee Diabetes Injection Pens Product Portfolio
- 4.8.5 Ganlee Recent Developments
- 4.9 Delfu
- 4.9.1 Delfu Company Information
- 4.9.2 Delfu Business Overview
- 4.9.3 Delfu Diabetes Injection Pens Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Delfu Diabetes Injection Pens Product Portfolio
- 4.9.5 Delfu Recent Developments
5 Global Diabetes Injection Pens Market Scenario by Region
- 5.1 Global Diabetes Injection Pens Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diabetes Injection Pens Sales by Region: 2021-2032
- 5.2.1 Global Diabetes Injection Pens Sales by Region: 2021-2026
- 5.2.2 Global Diabetes Injection Pens Sales by Region: 2027-2032
- 5.3 Global Diabetes Injection Pens Revenue by Region: 2021-2032
- 5.3.1 Global Diabetes Injection Pens Revenue by Region: 2021-2026
- 5.3.2 Global Diabetes Injection Pens Revenue by Region: 2027-2032
- 5.4 North America Diabetes Injection Pens Market Facts & Figures by Country
- 5.4.1 North America Diabetes Injection Pens Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diabetes Injection Pens Sales by Country (2021-2032)
- 5.4.3 North America Diabetes Injection Pens Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Diabetes Injection Pens Market Facts & Figures by Country
- 5.5.1 Europe Diabetes Injection Pens Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diabetes Injection Pens Sales by Country (2021-2032)
- 5.5.3 Europe Diabetes Injection Pens Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Diabetes Injection Pens Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diabetes Injection Pens Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diabetes Injection Pens Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diabetes Injection Pens Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diabetes Injection Pens Market Facts & Figures by Country
- 5.7.1 South America Diabetes Injection Pens Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diabetes Injection Pens Sales by Country (2021-2032)
- 5.7.3 South America Diabetes Injection Pens Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Diabetes Injection Pens Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diabetes Injection Pens Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diabetes Injection Pens Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diabetes Injection Pens Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Diabetes Injection Pens Sales by Type (2021-2032)
- 6.1.1 Global Diabetes Injection Pens Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Diabetes Injection Pens Sales Market Share by Type (2021-2032)
- 6.2 Global Diabetes Injection Pens Revenue by Type (2021-2032)
- 6.2.1 Global Diabetes Injection Pens Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diabetes Injection Pens Revenue Market Share by Type (2021-2032)
- 6.3 Global Diabetes Injection Pens Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diabetes Injection Pens Sales by Application (2021-2032)
- 7.1.1 Global Diabetes Injection Pens Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Diabetes Injection Pens Sales Market Share by Application (2021-2032)
- 7.2 Global Diabetes Injection Pens Revenue by Application (2021-2032)
- 7.2.1 Global Diabetes Injection Pens Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diabetes Injection Pens Revenue Market Share by Application (2021-2032)
- 7.3 Global Diabetes Injection Pens Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diabetes Injection Pens Value Chain Analysis
- 8.1.1 Diabetes Injection Pens Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diabetes Injection Pens Production Mode & Process
- 8.2 Diabetes Injection Pens Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diabetes Injection Pens Distributors
- 8.2.3 Diabetes Injection Pens Customers
9 Global Diabetes Injection Pens Analyzing Market Dynamics
- 9.1 Diabetes Injection Pens Industry Trends
- 9.2 Diabetes Injection Pens Industry Drivers
- 9.3 Diabetes Injection Pens Industry Opportunities and Challenges
- 9.4 Diabetes Injection Pens Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst